Stocks News

LAST PRICE
278.5500
TODAY'S CHANGE (%)
Trending Down-1.4000 (-0.5001%)

Bid / Lots
278.5500/ 1
Ask / Lots
279.4600/ 2
Open / Previous Close
281.7700 / 279.9500
Day Range
Low 276.7000
High 286.0050
52 Week Range
Low 119.7604
High 299.9800
Volume
75,467
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Jun 28, 2024
- Cantor Fitzgerald Starts Madrigal Pharmaceuticals With Neutral Rating, from 8:23AM ET on Friday Jun 28, 2024 by MT Newswires
  8:23AM ET on Friday Jun 28, 2024 by MT Newswires
  Companies Mentioned: MDGL
  08:23 AM EDT, 06/28/2024 (MT Newswires) -- Madrigal Pharmaceuticals (MDGL) has an average rating of outperform and a price target range of $150 to $507, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic ...
- DJ Madrigal Pharmaceuticals Initiated at Neutral by Cantor Fitzgerald, from 7:57AM ET on Friday Jun 28, 2024 by Dow Jones
  7:57AM ET on Friday Jun 28, 2024 by Dow Jones
  Companies Mentioned: MDGL
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MDGL/analyst-ratings
  
  (END) Dow Jones Newswires
  
  June 28, 2024 07:57 ET (11:57 GMT)

Today
- Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Zidesamtinib, and ALK-Selective Inhibitor, NVL-655, at the ESMO Congress 2024, from 4 hours ago by PR Newswire
  4 hours ago by PR Newswire
  Companies Mentioned: NUVL
- Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Zidesamtinib, and ALK-Selective Inhibitor, NVL-655, at the ESMO Congress 2024, from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: NUVL
Jul 11, 2024
- Nuvalent Names Henry Pelish Chief Scientific Officer; Shares Rise, from 12:10PM ET on Thursday Jul 11, 2024 by MT Newswires
  12:10PM ET on Thursday Jul 11, 2024 by MT Newswires
  Companies Mentioned: NUVL
- DJ S&P 500 Futures Fall In Premarket Trading; Delta Air Lines, Viking Therapeutics Lag, from 7:30AM ET on Thursday Jul 11, 2024 by Dow Jones
  7:30AM ET on Thursday Jul 11, 2024 by Dow Jones
  Companies Mentioned: IPG, NBIX, RRC, OMF, DAL, VKTX, COST
- Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer, from 6:30AM ET on Thursday Jul 11, 2024 by PR Newswire
  6:30AM ET on Thursday Jul 11, 2024 by PR Newswire
  Companies Mentioned: NUVL
- Press Release: Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer, from 6:30AM ET on Thursday Jul 11, 2024 by Dow Jones
  6:30AM ET on Thursday Jul 11, 2024 by Dow Jones
  Companies Mentioned: NUVL
- Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer, from 6:30AM ET on Thursday Jul 11, 2024 by Dow Jones
  6:30AM ET on Thursday Jul 11, 2024 by Dow Jones
  Companies Mentioned: NUVL
Jul 10, 2024
- Stifel Adjusts Price Target on Nuvalent to $115 From $103, Maintains Buy Rating, from 10:17AM ET on Wednesday Jul 10, 2024 by MT Newswires
  10:17AM ET on Wednesday Jul 10, 2024 by MT Newswires
  Companies Mentioned: NUVL
- DJ Nuvalent Is Maintained at Buy by Stifel, from 9:34AM ET on Wednesday Jul 10, 2024 by Dow Jones
  9:34AM ET on Wednesday Jul 10, 2024 by Dow Jones
  Companies Mentioned: NUVL
Jul 3, 2024
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:15PM ET on Wednesday Jul 03, 2024 by Business Wire
  4:15PM ET on Wednesday Jul 03, 2024 by Business Wire
  Companies Mentioned: SMMT

Madrigal Pharmaceuticals Inc
NASDAQ:MDGLUnited States

Search Criteria

Jun 28, 2024

Cantor Fitzgerald Starts Madrigal Pharmaceuticals With Neutral Rating, from 8:23AM ET on Friday Jun 28, 2024 by MT Newswires

DJ Madrigal Pharmaceuticals Initiated at Neutral by Cantor Fitzgerald, from 7:57AM ET on Friday Jun 28, 2024 by Dow Jones

Peers Headlines

Today

Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Zidesamtinib, and ALK-Selective Inhibitor, NVL-655, at the ESMO Congress 2024, from 4 hours ago by PR Newswire

Nuvalent to Present Updated Data for ROS1-Selective Inhibitor, Zidesamtinib, and ALK-Selective Inhibitor, NVL-655, at the ESMO Congress 2024, from 4 hours ago by Dow Jones

Jul 11, 2024

Nuvalent Names Henry Pelish Chief Scientific Officer; Shares Rise, from 12:10PM ET on Thursday Jul 11, 2024 by MT Newswires

DJ S&P 500 Futures Fall In Premarket Trading; Delta Air Lines, Viking Therapeutics Lag, from 7:30AM ET on Thursday Jul 11, 2024 by Dow Jones

Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer, from 6:30AM ET on Thursday Jul 11, 2024 by PR Newswire

Press Release: Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer, from 6:30AM ET on Thursday Jul 11, 2024 by Dow Jones

Nuvalent Announces Promotion of Henry Pelish, Ph.D. to Chief Scientific Officer, from 6:30AM ET on Thursday Jul 11, 2024 by Dow Jones

Jul 10, 2024

Stifel Adjusts Price Target on Nuvalent to $115 From $103, Maintains Buy Rating, from 10:17AM ET on Wednesday Jul 10, 2024 by MT Newswires

DJ Nuvalent Is Maintained at Buy by Stifel, from 9:34AM ET on Wednesday Jul 10, 2024 by Dow Jones

Jul 3, 2024

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:15PM ET on Wednesday Jul 03, 2024 by Business Wire